As of Dec 08
| -0.10 / -0.74%|
The 9 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 18.03, with a high estimate of 20.94 and a low estimate of 15.18. The median estimate represents a +34.96% increase from the last price of 13.36.
The current consensus among 9 polled investment analysts is to Buy stock in Astellas Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.